Cadrenal Therapeutics
CVKD
#10116
Rank
โ‚ฌ20.03 M
Marketcap
9,65ย โ‚ฌ
Share price
1.98%
Change (1 day)
-19.56%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2025 (TTM): -6,59ย โ‚ฌ

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -6,35ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -7,44ย โ‚ฌ an increase over its 2023 EPS that were of -7,92ย โ‚ฌ.

EPS history for Cadrenal Therapeutics from 2023 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-6,59ย โ‚ฌ-11.37%
2024-7,44ย โ‚ฌ-6.03%
2023-7,92ย โ‚ฌ